Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

ARB Drug Fights Diabetic Eye Disease Posted: Wednesday, October 01, 2008

New studies provide further evidence that candesartan, a blood pressure medicine, can cut the risk and severity of retinopathy in people who have diabetes, by as much as 18%, as well as blood pressure.

Scientists Turn Human Skin Cells Into Insulin-producing Cells Posted: Wednesday, September 24, 2008

Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the same hormone used to treat diabetes.

Pre-Meal Blood Glucose Values Best Gauge of True HbA1c Posted: Wednesday, September 24, 2008

For patients with type 1 or type 2 diabetes, pre-prandial glucose levels are generally more closely associated with long-term HbA1c levels than post-prandial glucose levels, according to a new study.

EASD: Byetta Wins In Head to Head Trial Over Januvia In Postprandial Glucose Posted: Wednesday, September 17, 2008

In a month-long head-to-head trial, the incretin mimetic exenatide (Byetta) reduced postprandial glucose in type 2 diabetes more than did sitagliptin (Januvia), an oral DPP-4 inhibitor, researchers reported.

New Gastrointestinal Treatment For Diabetes Using the EndoBarrier Liner Posted: Wednesday, September 17, 2008

GI Dynamics announces data demonstrating immediate and sustained reduction in HbA1c in patients with type 2 diabetes using EndoBarrier® Gastrointestinal Liner. Compelling clinical data highlighted at first World Congress on Interventional Therapies for Type 2 Diabetes show improved glycemic control and weight reduction in uncontrolled diabetics.

EASD: Early Intensive Glucose Control Pays Dividends Posted: Wednesday, September 17, 2008

A 10-year follow-up of a landmark trial of intensive glucose control in type 2 diabetes has suggested that the clinical benefit was more than durable and rose over time to a reduction or 15% for myocardial infarction and a 13% reduction in the relative risk of death from any cause.

Study 2008: Healthcare Costs To Rise AGAIN! Posted: Wednesday, September 10, 2008

We continue to see healthcare costs rising and those with diabetes will certainly feel it the most. Let's hope that the new president will do something to help. Consider getting involved with one of the presidential candidates after viewing their ideas on improving healthcare in this country.

New Analysis Shows Lower Not Necessarily Better When It Comes to BP Posted: Wednesday, September 10, 2008

New observational analysis of the ONTARGET study shows that lower is not necessarily better when it comes to blood pressure in this patient population, with coronary heart disease or diabetes plus additional risk factors. Although there was evidence that lower was better in terms of stroke, there was a suggestion of harm when BP was reduced below 130 mm Hg systolic for the outcome of cardiovascular death in diabetics. The findings suggest that in high-risk people, the [current] guidelines of 'the lower, the better' may not apply.

Januvia/Byetta Becoming First and Second-Line Therapy for Type 2 Diabetes Posted: Wednesday, September 10, 2008

New research reports that Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.

Novel Short-Term Weight-Loss Approach Works Long-Term Posted: Wednesday, September 10, 2008

A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term. The focus was on weight loss and not as much on glucose control.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.